|Articles|June 1, 2002
Results reported: Ocular implant safe for AMD in early tests
Rockville, MD-Ocular implants of EntreMed's 2-methoxyestradiol (Panzem) showed no toxicity and effectively inhibited the growth of new blood vessels in preclinical models of age-related macular degeneration (AMD), the company said.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
























